The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
FDG PET, PET/CT, and Breast Cancer Imaging
Abstract
Currently, the clinical role of positron emission tomography (PET) and PET/computed tomography (CT) in patients with breast cancer is to provide additional information in select scenarios in which results of conventional imaging are indeterminate or of limited utility. There is currently no clinical role for fluorodeoxyglucose (FDG) PET in detection of breast cancer or evaluation of axillary lymph nodes, but these are areas of active research. FDG PET is complementary to conventional staging procedures and should not be a replacement for either bone scintigraphy or diagnostic CT. FDG PET and PET/CT have been shown to be particularly useful in the restaging of breast cancer, in evaluation of response to therapy, and as a problem-solving method when results of conventional imaging are equivocal. In these situations, FDG PET often demonstrates locoregional or unsuspected distant disease that affects management. PET has demonstrated a particular capability for evaluation of chemotherapy response in both patients with locally advanced breast carcinoma and those with metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wolmark, N., Wang, J., Mamounas, E., Bryant, J., & Fisher, B. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003469 · Cited by 1,299
Wahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., & Cody, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2101 · Cited by 605
Cook, G. J., Houston, S., Rubens, R., Maisey, M. N., & Fogelman, I. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3375 · Cited by 562
Schelling, M., Avril, N., Nährig, J., Kuhn, W., Römer, W., Sattler, D., Werner, M., Dose, J., Jänicke, F., Graeff, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1689 · Cited by 522
Metabolic Flare: Indicator of Hormone Responsiveness in Advanced Breast Cancer
Mortimer, J. E., Dehdashti, F., Siegel, B. A., Trinkaus, K., Katzenellenbogen, J. A., & Welch, M. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2797 · Cited by 410
Smith, I. C., Welch, A. E., Hutcheon, A. W., Miller, I. D., Payne, S., Chilcott, F., Waikar, S., Whitaker, T., Ah-See, A. K., Eremin, O., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1676 · Cited by 406
Linden, H. M., Stekhova, S. A., Link, J. M., Gralow, J. R., Livingston, R. B., Ellis, G. K., Petra, P. H., Peterson, L. M., Schubert, E. K., Dunnwald, L. K., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3810 · Cited by 394
Self-citationWahl, R. L., Siegel, B. A., Coleman, R. E., & Gatsonis, C. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.148 · Cited by 345
Moon, D. H., Maddahi, J., Silverman, D. H. S., Glaspy, J. A., Phelps, M. E., & Hoh, C. K. (1998) · PubMed · Cited by 274
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.
Mankoff, D. A., Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Charlop, A. W., Lawton, T. J., Schubert, E. K., Tseng, J. R., & Livingston, R. B. (2002) · PubMed · Cited by 253
Self-citationAvril, N., Dose, J., Jänicke, F., Bense, S., Ziegler, S., Laubenbacher, C., Römer, W., Pache, H., Herz, M., Allgayer, B., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1848 · Cited by 242
Schwarz, J., Bader, M., Jenicke, L., Hemminger, G., Jänicke, F., & Avril, N. E. (2005) · PubMed · Cited by 227
Clinicopathologic factors associated with false negative FDG–PET in primary breast cancer
Kumar, R., Chauhan, A., Zhuang, H., Chandra, P., Schnall, M., & Alavi, A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9159-2 · Cited by 226
Bassa, P., Kim, E. E., INOUE, T., Wong, F. C., Korkmaz, M., Yang, D. J., Wong, W., Hicks, K., Buzdar, A. U., & Podoloff, D. A. (1996) · PubMed · Cited by 210
FDG uptake, tumour characteristics and response to therapy: A review
SMITH, T. A. D. (1998) · Nuclear Medicine Communications · doi:10.1097/00006231-199802000-00002 · Cited by 200
Mankoff, D. A., Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Schubert, E. K., Tseng, J. R., Lawton, T. J., Linden, H. M., & Livingston, R. B. (2003) · PubMed · Cited by 200
Self-citationEvolving role of positron emission tomography in breast cancer imaging
Eubank, W. B., & Mankoff, D. A. (2005) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2004.11.001 · Cited by 192
Self-citationA meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases
Isasi, C. R., Moadel, R. M., & Blaufox, M. D. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-3291-7 · Cited by 181
Utech, C. I., Young, C. S., & Winter, P. F. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01249621 · Cited by 165
Machiavelli, M. R., Romero, A. O., Pérez, J. E., Lacava, J. A., Domínguez, M. E., Rodriguez, R. J., Barbieri, M. R., Acuña, L. A. R., Acuña, J. M. R., Langhi, M. J., et al. (1998) · PubMed · Cited by 144
Lovrics, P. J., Chen, V., Coates, G., Cornacchi, S. D., Goldsmith, C. H., Law, C., Levine, M. N., Sanders, K., & Tandan, V. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.11.033 · Cited by 114
Fueger, B. J., Weber, W., Quon, A. S. W., Crawford, T. L., Allen-Auerbach, M., Halpern, B. S., Ratib, O. M., Phelps, M. E., & Czernin, J. G. (2005) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0013-4 · Cited by 112
van der Hoeven, J. J. M., Hoekstra, O. S., Comans, E. F. I., Pijpers, R. J., Boom, R. P. A., van Geldere, D., Meijer, S., Lammertsma, A. A., & Teule, G. J. J. (2002) · Annals of Surgery · doi:10.1097/00000658-200211000-00012 · Cited by 108
Cachin, F., Prince, H., Hogg, A., Ware, R., & Hicks, R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6326 · Cited by 99
Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
Eubank, W. B., Mankoff, D. A., Schmiedl, U. P., Winter, T. C., Fisher, E. R., Olshen, A. B., Graham, M. M., & Eary, J. F. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.4.9763005 · Cited by 90
Self-citationBarranger, E., Grahek, D., Antoine, M., Montravers, F., Talbot, J., & Uzan, S. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.12.019 · Cited by 89
Kamel, E. M., Wyss, M. T., Fehr, M. K., von Schulthess, G. K., & Goerres, G. W. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0424-z · Cited by 86
Gil–Rendo, A., Zornoza, G., García‐Velloso, M. J., Regueira, F. M., Beorlegui, C., & Cervera, M. (2006) · British journal of surgery · doi:10.1002/bjs.5338 · Cited by 81
Chen, X., Moore, M. O., Lehman, C. D., Mankoff, D. A., Lawton, T. J., Peacock, S., Schubert, E. K., & Livingston, R. B. (2004) · Academic Radiology · doi:10.1016/j.acra.2004.07.007 · Cited by 74
Self-citationFDG PET positive lymph nodes are highly predictive of metastasis in breast cancer
Kumar, R., Zhuang, H., Schnall, M. D., Conant, E. F., Damia, S., Weinstein, S. P., Chandra, P., Czerniecki, B. J., & Alavi, A. A. (2006) · Nuclear Medicine Communications · doi:10.1097/00006231-200603000-00005 · Cited by 73
Fehr, M. K., Hornung, R., Varga, Z., Burger, D., Hess, T., Haller, U., Fink, D. A., von Schulthess, G. K., & Steinert, H. C. (2004) · The Breast Journal · doi:10.1111/j.1075-122x.2004.21455.x · Cited by 68
Burcombe, R. J., Makris, A., Pittam, M. R., Lowe, J., Emmott, J., & Wong, W. L. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00379-3 · Cited by 68
Current and future uses of positron emission tomography in breast cancer imaging
Eubank, W. B., & Mankoff, D. A. (2004) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2004.03.007 · Cited by 55
Self-citationMankoff, D. A., Muzi, M., & Krohn, K. A. (2003) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2003.09.002 · Cited by 39
Self-citation
Cited by
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Anderson, B., Burstein, H. J., Chew, H., Dang, C., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0030 · Cited by 951
Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0012 · Cited by 450
Bioelectrical Impedance Methods for Noninvasive Health Monitoring: A Review
Bera, T. K. (2014) · Journal of Medical Engineering · doi:10.1155/2014/381251 · Cited by 407
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0037 · Cited by 304
Yao, D., Wang, Y., Zou, R., Bian, K., Liu, P., Shen, S., Yang, W., Zhang, B., & Wang, D. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b20147 · Cited by 151
Metadata
- Authors
- Rosen, E. L., Eubank, W. B., & Mankoff, D. A.
- Venue
- RadioGraphics
- Published
- 2007-10
- Volume
- 27
- Issue
- suppl_1
- Pages
- S215-S229
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2153283011
- Cited by
- 265
- References
- 34
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.